Revance Therapeutics
+$1.17 (+4.20%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell RVNC and other stocks, options, and ETFs commission-free!
About RVNC
Revance Therapeutics, Inc. Common Stock, also called Revance Therapeutics, is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications.
CEO
Mark J. Foley
Employees
470
Headquarters
Nashville, Tennessee
Founded
1999
RVNC Key Statistics
Market Cap
2.03B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
425.64K
High Today
$29.13
Low Today
$27.88
Open Price
$27.94
Volume
391.61K
52 Week High
$34.62
52 Week Low
$18.71
Analyst Ratings
100%
of 10 ratings
Buy
100%
Hold
0%
Sell
0%
RVNC Earnings
-$1.34
-$1.19
-$1.05
-$0.90
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$1.09 per share
Actual
-$1.08 per share